Chandler K E, Kidd A, Al-Gazali L, Kolehmainen J, Lehesjoki A-E, Black G C M, Clayton-Smith J
Academic Unit of Medical Genetics and Regional Genetics Service, St Mary's Hospital, Manchester, UK.
J Med Genet. 2003 Apr;40(4):233-41. doi: 10.1136/jmg.40.4.233.
Cohen syndrome is a rare, recessively inherited condition associated with facial dysmorphism, developmental delay, and visual disability. A delay in making the diagnosis commonly occurs, contributed to by the lack of a definitive molecular test and the clinical variability of published case reports. A specific clinical phenotype has been delineated in a homogeneous cohort of Finnish Cohen syndrome patients, but the applicability of their diagnostic criteria to non-Finnish patients has been debated. Detailed delineation of Cohen syndrome in patients from outside Finland is therefore warranted. We report on the clinical features of 33 non-Finnish Cohen syndrome patients. Variability within the clinical spectrum is identified and the natural history of Cohen syndrome described. Diagnostic guidelines for facilitating accurate and early diagnosis are discussed. Results from molecular genetic analysis using markers located within the previously mapped COH1 critical region support allelic but not genetic heterogeneity in this UK cohort.
科恩综合征是一种罕见的隐性遗传疾病,与面部畸形、发育迟缓及视力残疾有关。由于缺乏确定性的分子检测方法以及已发表病例报告的临床变异性,诊断往往会延迟。在一组同质化的芬兰科恩综合征患者中已明确了一种特定的临床表型,但他们的诊断标准对非芬兰患者的适用性一直存在争议。因此,有必要对芬兰以外的患者进行科恩综合征的详细描述。我们报告了33例非芬兰科恩综合征患者的临床特征。确定了临床谱系内的变异性,并描述了科恩综合征的自然病史。讨论了有助于准确和早期诊断的诊断指南。使用位于先前定位的COH1关键区域内的标记进行分子遗传分析的结果支持该英国队列中的等位基因异质性而非基因异质性。